Por: The Advocate Health September 26, 2022
Why do people resist enrolling in clinical trials for Alzheimer’s disease?Some of the key challenges that researchers face in conducting studies on Alzheimer’s disease and recruiting candidates include barriers such as lack of time, lack of available diagnostic clinical tools and the potential research candidate’s concerns over risks to them of experimental protocols or invasive procedures. Additionally, lack of proximity to a research... + full article
The Hill USA Health September 28, 2022
Tonight, Jupiter will be the closest it’s been to Earth decades, and if the sky’s clear, you should be able to and some of its moons. In health news, Pfizer wants the FDA to authorize the omicron booster shot for kids ages 5 to 11. and . Someone forward you this... + más
Pfizer asks FDA to authorize omicron Covid booster shots for kids ages 5 to 11 | CNBC
Moderna asks FDA to authorize omicron Covid boosters for children as young as 6 years old | CNBC
Portland Press Herald USA Health September 28, 2022
An experimental Alzheimer’s drug slowed cognitive and functional decline by 27 percent in a closely watched clinical trial, the sponsors of the medication said Tuesday, increasing the therapy’s chance for approval as soon as early next year. Japanese drugmaker Eisai and its... + más
Alzheimer's drug slows progression of cognitive decline in clinical trial, drugmakers say | CNN
New test can detect plaques early in the disease: Alzheimer's Q&A | The Advocate
NBC 6 South Florida USA World September 28, 2022
AP Photo/Steven Senne, File Shares of Biogen and other drugmakers researching Alzheimer’s disease soared early Wednesday after Japan’s Eisai Co. said its potential treatment appeared to slow the fatal disease in a late-stage study. The drugmaker said early results showed... + más
COVID-19 in seniors linked to increased Alzheimer’s risk, study finds | Portland Press Herald
How To Spot The Early Signs Of Alzheimer's | Newsweek
Politico USA Health September 24, 2022
Under fire from critics over its privacy practices, Facebook is implementing a sweeping ban on advertisers targeting patients with messages based on their health conditions. And that could be bad news for drug development. The decision by the social media giant, which takes... + más
Facebook will experience its slowest US user growth ever in 2021 | Business Insider
Council Post: Eight Strategies You Should Consider When Marketing A Company Using Facebook Messenger | Forbes
RTTNews USA Tech September 24, 2022
American nonprofit medical center Mayo Clinic has partnered Dutch blockchain startup Triall to use its blockchain-integrated eClinical platform to advance clinical trial design and management of study data. The move is seen as a game changer and will lead to a global... + más
KKR Blockchain Access To $4 Billion Fund Opens Door To Crypto Investors | Forbes
'Merge' Upgrade To Take Ethereum Blockchain Greener | RTTNews
10 WBNS USA Health September 19, 2022
COLUMBUS, Ohio — National Lung Cancer Awareness Day was in August, but for people who are recently diagnosed or in treatment, the disease is a daily reality. But new treatments and research are changing the statistics and giving hope to those who hear the words, You have lung... + más
In a nod to JFK, Biden pushing 'moonshot' to fight cancer | 10 WBNS
How concierge medicine is changing the way people access health care | The Advocate
The Advocate USA Health September 17, 2022
Is sildenafil being considered as a potential treatment for Alzheimer’s disease?Sildenafil could potentially be used as a treatment for Alzheimer’s disease, according to findings recently published in Nature Aging by Feixong Cheng, of the Cleveland Clinic.Per MedlinePlus, an... + más
There's a growing dementia crisis in the veteran community: Alzheimer's Q&A | The Advocate
US warns monkeypox could mutate to resist antiviral drug | ABC News
About iurex | Privacy Policy | Disclaimer |